Dr. James Wu, MD

Dr. Wu practices at Olive View-UCLA Medical Center in Sylmar, California, part of County of Los Angeles.

Dr. Wu's NPI, 1164721411, was assigned on March 24, 2011. Dr. Wu graduated from University of Colorado Anschutz Medical Campus in 2011. Dr. Wu holds California license A125315.

Dr. Wu's primary practice is Olive View-UCLA Medical Center, at 14445 Olive View Drive, Sylmar, CA 91342 in Los Angeles County. The practice phone is (818) 364-1555.

Dr. Wu's primary practice is Olive View-UCLA Medical Center in Sylmar, California, part of County of Los Angeles. Dr. Wu is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Associated General Surgeons. Dmand AI also links Dr. Wu to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wu practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Wu's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Wu is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Wu's licenses on file in 2 states: California and New York.

Dmand AI lists thyroid surgery among the conditions Dr. Wu treats.

CMS data shows 143 Medicare services from Dr. Wu across 7 procedure codes in 2024, for 91 Medicare patients. Medicare paid $23,289 for them.

CMS counts 91 Medicare patients who saw Dr. Wu in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wu's median patient age at 55, with 73% women.

In 2024, Dr. Wu wrote 16 Medicare Part D claims. 75% of them were for generic drugs. They cover 1 drug, with $280 in total drug cost. In 2021, CMS named 69 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Wu for performance year 2024, reported as part of a group. Dr. Wu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wu as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 35 papers to Dr. Wu, published from 2014 to 2024. 2019 was the busiest year, with 4. The most frequent topics are Evidence-Based Medicine. Dr. Wu's most frequent co-authors are Kyle A. Zanocco, MD, Anoushka M. Afonso, MD and Michael B. Atkins, MD.

Dmand AI links Dr. Wu to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Thyroid Neoplasms, Breast Neoplasms and Thyroid Nodule. University of California, Los Angeles sponsors the most, 2.

CMS Open Payments shows 28 general payments to Dr. Wu from 7 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 52% of the total. Intuitive Surgical, Inc. paid the most, $1,358.

Dmand AI lists 4 awards for Dr. Wu, most recently Emergency Med Consultant Award Nominee in 2016.

Dr. Wu graduated from University of Colorado Anschutz Medical Campus in 2011. Dr. Wu is a member of American Association of Endocrine Surgeons and ATA.

Dr. Wu is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.